Clinical Trial Results
Showing:
All studies
[change]
Condition: Arthritis
25 trials found
New Search
Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
RECRUITING
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
RECRUITING
A Multi-Center Study Assessing the Safety and Efficacy of the LEGION Medial Stabilized (MS) Insert in Patients Undergoing a Total Knee Arthroplasty (TKA)
RECRUITING
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
RECRUITING
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
RECRUITING
Knee Ligament Stiffness Across Ethnicities Before and After Osteoarthritis Treatment
RECRUITING
Evaluating the Efficacy of a Mobile Application in Postoperative Rehabilitation
RECRUITING
Studies of the Natural History of Rheumatic Diseases
RECRUITING
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
RECRUITING
Clinical Study Comparing Diosmin vs Rebamipide as Adjuvant Therapies vs Conventional Therapy in Patients With Rheumatoid Arthritis
RECRUITING
Natural History and Development of Spondyloarthritis
RECRUITING
Korean Post-marketing Surveillance for Xeljanz XR
RECRUITING
Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis
RECRUITING
Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis
RECRUITING
A Phase 1b Open-label Study to Evaluate Safety of Plamotamab in Participants With Rheumatoid Arthritis
RECRUITING
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
RECRUITING
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RECRUITING
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
RECRUITING
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
RECRUITING
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
RECRUITING
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RECRUITING
A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)
RECRUITING
A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting
RECRUITING
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
RECRUITING
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
RECRUITING